8-K//Current report
Ambrx Biopharma Inc. 8-K
Accession 0001193125-23-060814
CIK 0001836056operating
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 9:00 AM ET
Size
215.3 KB
Accession
0001193125-23-060814
Documents
- 8-Kd473459d8k.htmPrimary
8-K
- EX-99.1d473459dex991.htm
EX-99.1
- EX-101.SCHamam-20230305.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.DEFamam-20230305_def.xml
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
- EX-101.LABamam-20230305_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREamam-20230305_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- GRAPHICg473459g0306064429819.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLd473459d8k_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-23-060814-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Ambrx Biopharma Cayman, Inc.
CIK 0001836056
Entity typeoperating
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001836056
Filing Metadata
- Form type
- 8-K
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 9:00 AM ET
- Size
- 215.3 KB